Monte Rosa Therapeutics Inc (GLUE)

Investing Cash Flow

-$28.86M

Quarterly · Period ending: · USD

GLUE logo

GLUE Investing Cash Flow

Latest reported-$28.86M
GLUE Quarterly Cash from Investing (-$13.00K → -$28.86M)
High-resolution chart · PNG

GLUE investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Monte Rosa Therapeutics Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-28,860,000
-260,997,000
-65,066,000
38,138,000
25,324,000
-100,229,000
-30,896,000
37,749,000
-61,158,000
9,853,000
14,297,000
35,628,000
18,550,000
20,326,000
-53,939,000
29,489,000
-14,249,000
-180,520,000
-3,047,000
-1,688,000
-2,701,000
-2,217,000
-1,186,000
-930,000
-1,260,000
-13,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.